Protocols → The Triple Protocol

The Triple Protocol

Three receptors. One result.

Emerging evidence12+ weeksBest for: Experienced GLP-1 users wanting maximum effect, those who have plateaued on Semaglutide
Start this protocol

What this protocol does

Retatrutide is a triple GLP-1, GIP, and glucagon receptor agonist — the most advanced metabolic compound currently available in research.

GLP-1 and GIP work as in Tirzepatide. The glucagon receptor component adds direct thermogenic and visceral fat targeting effects.

Three simultaneous mechanisms produce outcomes that single and dual agonists cannot match at equivalent doses. This is the frontier of GLP-1 research.

What's in this protocol

Retatrutide

Maximum metabolic effect across three receptors

GLP-1 + GIP + glucagon receptor agonism

Dose: 2–12mg
Timing: Once weekly SC

What to expect

What's happening in your body

  1. Week 1

    Three receptors activated. Appetite reduction and increased energy expenditure begin.

  2. Week 2

    Adaptation phase — slower ramp than other GLP-1s. Body adjusting to triple mechanism.

  3. Weeks 3–4

    Strong fat loss including visceral. Thermogenic effect noticeable.

  4. Beyond 4

    Continued progress at doses other GLP-1s cannot match.

What you actually feel

  1. Week 1

    Strong appetite reduction, slightly warmer than baseline (glucagon component).

  2. Week 2

    Adaptation — side effects easing.

  3. Weeks 3–4

    Rapid visible composition changes.

  4. Beyond 4

    Sustained transformation if escalated patiently.

Your dosing guide

Start 2mg per week. Escalate slowly — 2 → 4 → 6 → 8mg over 16 weeks minimum.

For research purposes only. This is not medical advice.

Protocol FAQ

Ready to start?

Message us on Line — we'll build your exact protocol.

Start on Line

@siamlabs · siamlabs.co

For research purposes only · Not intended for human consumption · Keep out of reach of children